| Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies EG Oakes, E Dillon, KA Buhler, H Guan, M Paudel, K Marks, I Adejoorin, ... Journal of Autoimmunity 148, 103299, 2024 | | 2024 |
| Air Pollution and Rheumatoid Arthritis Risk and Progression: Implications for the Mucosal Origins Hypothesis and Climate Change for RA Pathogenesis KJ Bade, KT Mueller, JA Sparks Current Rheumatology Reports, 1-11, 2024 | | 2024 |
| 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with … SR Johnson, EJ Bernstein, MB Bolster, JH Chung, SK Danoff, MD George, ... Arthritis Care & Research, 2024 | 3 | 2024 |
| Highlights of Interdisciplinary Care in Rheumatology AB Dua, JA Sparks Rheumatic Disease Clinics 50 (3), xiii-xiv, 2024 | | 2024 |
| Immune mechanisms in fibrotic interstitial lung disease M Kamiya, H Carter, MS Espindola, TJ Doyle, JS Lee, LT Merriam, ... Cell 187 (14), 3506-3530, 2024 | | 2024 |
| Ultra‐Processed Food Intake and Risk of Systemic Lupus Erythematosus among Women followed in the Nurses’ Health Study Cohorts S Rossato, EG Oakes, M Barbhaiya, JA Sparks, S Malspeis, WC Willett, ... Arthritis Care & Research, 2024 | | 2024 |
| Initiation Trends of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis Adults, 2001-2021 YL Lee, JA Sparks, P Yalamanchili, DB Horton, ZM Khan, J Barone, ... Available at SSRN 4871603, 2024 | | 2024 |
| Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease RK Venkat, K Hayashi, PA Juge, G McDermott, M Paudel, X Wang, ... Clinical Rheumatology, 2024 | | 2024 |
| Serum Biomarkers of Pulmonary Damage and Risk for Progression of Rheumatoid Arthritis-Associated Interstitial Lung Disease SH Chang, YB Park, G McDermott, ML Paudel, K Hayashi, H You-Jung, ... | | 2024 |
| RPA3-UMAD1 rs12702634 and rheumatoid arthritis-associated interstitial lung disease in European ancestry PA Juge, JA Sparks, S Gazal, E Ebstein, R Borie, MP Debray, ... Rheumatology Advances in Practice, rkae059, 2024 | | 2024 |
| Rheumatoid arthritis and changes on spirometry by smoking status in two prospective longitudinal cohorts K Hayashi, GC McDermott, PA Juge, M Moll, MH Cho, X Wang, ... RMD open 10 (2), e004281, 2024 | | 2024 |
| POS0034 ASSOCIATIONS OF 31 NOVEL COPA NON-SYNONYMOUS VARIANTS WITH AUTOIMMUNE AND INFLAMMATORY CLINICAL PHENOTYPES AMONG 160,365 INDIVIDUALS: DEFINING A COPA SPECTRUM DISORDER PA Juge, VL Kronzer, C David-Gabarre, ML Frémond, R Kechiche, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 251-251, 2024 | | 2024 |
| OP0202 DECIPHERING RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE PHENOTYPES USING UNSUPERVISED HIERARCHICAL CLUSTERING ANALYSIS: RESULTS FROM A LARGE COLLABORATIVE … PA Juge, B Granger, L El Houari, G Mcdermott, T Doyle, C Kelly, G Koduri, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 78-79, 2024 | | 2024 |
| AB0083 THE IMPACT OF COVID-19 AND ‘LONG COVID’ON SELF-REPORTED DISEASE ACTIVITY, DISABILITY, AND QUALITY OF LIFE IN PEOPLE WITH INFLAMMATORY ARTHRITIS ZS Wallace, M Lin, X Wang, N Patel, Y Kawano, A Schiff, A King, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 1272-1273, 2024 | | 2024 |
| POS0081 ASSOCIATIONS OF CIRCULATING INFLAMMATORY CYTOKINES WITH LONG COVID AMONG PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES JA Sparks, X Wang, PY Lee, K Brodeur, M Lin, N Patel, Y Kawano, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 313-314, 2024 | | 2024 |
| Rheumatoid Arthritis and Bronchiectasis Risk: Additional Evidence Linking Autoimmunity and Airways Disease GC McDermott, JA Sparks Chest 165 (6), 1276-1277, 2024 | 1 | 2024 |
| High Interleukin-13 level is associated with disease stability in interstitial Lung disease EK Joerns, D Karp, S Zhang, JA Sparks, TN Adams, UE Makris, ... Heliyon, 2024 | | 2024 |
| Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis JA Sparks, P Dieudé, AM Hoffmann-Vold, GR Burmester, SLF Walsh, ... BMC rheumatology 8 (1), 19, 2024 | 1 | 2024 |
| Persistence and Treatment Patterns Among Biologic/JAKi-Naïve Medicare Beneficiaries with ACPA and RF+ Rheumatoid Arthritis Initiating Biologic or Targeted Synthetic DMARDs TT Schwartz, H Zheng, L N'Dri, SH Park, K Norris, V Patel, SB Robinson, ... | | 2024 |
| Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management N Singh, A Shahane, JA Sparks, S Bitoun, LC Cappelli Rheumatic Disease Clinics 50 (2), 269-279, 2024 | | 2024 |
Zachary S. WallacePhysician-Scientist, Rheumatology Unit, Massachusetts General HospitalVerified email at mgh.harvard.edu